Abstract
Background: Apicidin, as an inhibitor of histone deacetylase, showed a wide range of antiproliferative activity against various cancer cell lines. Apicidin has also been reported to induce apotosis via Fas/Fas ligand. Yet few studies have been focused on mitochondrial pathway for its anti-tumor activity.
Objective: In this study, we evaluated its involved mitochondrial mechanism against non-small cell lung cancer GLC-82 cells.
Method: Apicidin was isolated from the mangrove endophtic fungi Fusarium sp. by solvent extraction and column chromatography. Its structure was elucidated by MS and NMR spectroscopic data, and comparison of those data with published data. Furthermore, anti-tumor activity and mitochondrial pathway of apicidin against GLC-82 cells were studied.
Results: Apicidin was obtained from secondary metabolites of Fusarium sp., and it showed potent inhibitory activity against GLC-82 cells with the IC50 value of 6.94 ± 0.27 µM. Furthermore, apicidin suppressed proliferation and invasion, and induced apoptosis via mitochondrial pathway in GLC-82 cells, including loss of ΔΨm, release of cytochrome c from mitochondria, activation of caspase-9 and -3, and cleavage of poly-ADP-ribose polymerase.
Conclusion: Apicidin, an inhibitor of histone deacetylase obtained from the mangrove endophytic fungi Fusarium sp., not only inhibited proliferation and invasion of GLC-82 cells, but also induced apoptosis via the mitochondrial pathway.
Keywords: Apicidin, Fusarium sp, histone deacetylase, mitochondrial pathway, apoptosis, proliferation, invasion.
Anti-Cancer Agents in Medicinal Chemistry
Title:Apicidin Inhibited Proliferation and Invasion and Induced Apoptosis via Mitochondrial Pathway in Non-small Cell Lung Cancer GLC-82 Cells
Volume: 17 Issue: 10
Author(s): Jianye Zhang, Zhenzhu Lai, Wenjing Huang, Huiping Ling, Minting Lin, Sili Tang, Yun Liu and Yiwen Tao*
Affiliation:
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436,China
Keywords: Apicidin, Fusarium sp, histone deacetylase, mitochondrial pathway, apoptosis, proliferation, invasion.
Abstract: Background: Apicidin, as an inhibitor of histone deacetylase, showed a wide range of antiproliferative activity against various cancer cell lines. Apicidin has also been reported to induce apotosis via Fas/Fas ligand. Yet few studies have been focused on mitochondrial pathway for its anti-tumor activity.
Objective: In this study, we evaluated its involved mitochondrial mechanism against non-small cell lung cancer GLC-82 cells.
Method: Apicidin was isolated from the mangrove endophtic fungi Fusarium sp. by solvent extraction and column chromatography. Its structure was elucidated by MS and NMR spectroscopic data, and comparison of those data with published data. Furthermore, anti-tumor activity and mitochondrial pathway of apicidin against GLC-82 cells were studied.
Results: Apicidin was obtained from secondary metabolites of Fusarium sp., and it showed potent inhibitory activity against GLC-82 cells with the IC50 value of 6.94 ± 0.27 µM. Furthermore, apicidin suppressed proliferation and invasion, and induced apoptosis via mitochondrial pathway in GLC-82 cells, including loss of ΔΨm, release of cytochrome c from mitochondria, activation of caspase-9 and -3, and cleavage of poly-ADP-ribose polymerase.
Conclusion: Apicidin, an inhibitor of histone deacetylase obtained from the mangrove endophytic fungi Fusarium sp., not only inhibited proliferation and invasion of GLC-82 cells, but also induced apoptosis via the mitochondrial pathway.
Export Options
About this article
Cite this article as:
Zhang Jianye , Lai Zhenzhu , Huang Wenjing , Ling Huiping , Lin Minting , Tang Sili , Liu Yun and Tao Yiwen *, Apicidin Inhibited Proliferation and Invasion and Induced Apoptosis via Mitochondrial Pathway in Non-small Cell Lung Cancer GLC-82 Cells, Anti-Cancer Agents in Medicinal Chemistry 2017; 17 (10) . https://dx.doi.org/10.2174/1871520617666170419120044
DOI https://dx.doi.org/10.2174/1871520617666170419120044 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
Current Pharmaceutical Design Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
Reviews on Recent Clinical Trials DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases
Current Drug Metabolism Advances and Implications in Nanotechnology for Lung Cancer Management
Current Drug Metabolism Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Current Molecular Medicine Structural Models of Protein-DNA Complexes Based on Interface Prediction and Docking
Current Protein & Peptide Science Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
Current Pharmaceutical Design Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Evaluation of Novel Pyrimidine Derivatives as EGFR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
Current Neurovascular Research Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design Targeting the Hedgehog Pathway: The development of Cyclopamine and the Development of Anti-Cancer Drugs Targeting the Hedgehog Pathway
Mini-Reviews in Medicinal Chemistry Regulation of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor Signaling by Plant Flavonoids
Mini-Reviews in Medicinal Chemistry EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy
Recent Patents on Anti-Cancer Drug Discovery A Focus on Heme Oxygenase-1 (HO-1) Inhibitors
Current Medicinal Chemistry Viral-Mediated Gene Transfer for Cancer Treatment
Current Pharmaceutical Biotechnology